Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant.

[1]  P. Chouvenc,et al.  Formulation approach for the development of a stable, lyophilized formaldehyde-containing vaccine. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  K. Jansen,et al.  A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile , 2013, Microbiology.

[3]  J. Bodmer,et al.  Development and Optimization of a Novel Assay To Measure Neutralizing Antibodies against Clostridium difficile Toxins , 2013, Clinical and Vaccine Immunology.

[4]  R. Carman,et al.  A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models. , 2012, Vaccine.

[5]  Nigel P. Minton,et al.  The role of toxin A and toxin B in Clostridium difficile infection , 2010, Nature.

[6]  K. Aktories,et al.  Clostridium difficile Glucosyltransferase Toxin B-essential Amino Acids for Substrate Binding* , 2007, Journal of Biological Chemistry.

[7]  Klaus Aktories,et al.  Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity* , 2007, Journal of Biological Chemistry.

[8]  P. Højrup,et al.  Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin. , 2007, Vaccine.

[9]  W. Hennink,et al.  Identification of formaldehyde-induced modifications in proteins: reactions with insulin. , 2006, Bioconjugate chemistry.

[10]  M. Win,et al.  Stability of Russell's viper venom toxoid (lyophilized form) on storage. , 1999, Japanese journal of infectious diseases.

[11]  S. Munro,et al.  A Common Motif of Eukaryotic Glycosyltransferases Is Essential for the Enzyme Activity of Large Clostridial Cytotoxins* , 1998, The Journal of Biological Chemistry.

[12]  A. Klibanov,et al.  Deterioration of lyophilized pharmaceutical proteins. , 1998, Biochemistry. Biokhimiia.

[13]  L. Nencioni,et al.  The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization. , 1996, Developments in biological standardization.

[14]  S. Cockle,et al.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine , 1990, Infection and immunity.

[15]  J. Clements,et al.  Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins , 1990, Infection and immunity.

[16]  L. Nencioni,et al.  Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough , 1990, Infection and immunity.

[17]  L. Nencioni,et al.  Mutants of pertussis toxin suitable for vaccine development. , 1989, Science.

[18]  M. Cadoz,et al.  Acellular pertussis vaccines: evaluation of reversion in a nude mouse model. , 1988, Journal of biological standardization.

[19]  F. Dorner,et al.  Bacterial toxin vaccines. , 1985, Vaccine.

[20]  S. Cryz,et al.  Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means. , 1983, Reviews of infectious diseases.

[21]  M. Pollack,et al.  Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. , 1982, The Journal of infectious diseases.

[22]  A. Ohsaka,et al.  Standardization of habu (Trimeresurus flavoviridis) snake-venom toxoid. , 1978, Toxicon : official journal of the International Society on Toxinology.

[23]  J. Holmgren,et al.  Development of improved cholera vaccine based on subunit toxoid , 1977, Nature.

[24]  E. Fuerer,et al.  Preparation of a Purified Antigenic Cholera Toxoid , 1976, Infection and immunity.

[25]  T. Uchida,et al.  Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. , 1973, The Journal of biological chemistry.

[26]  R. Murata,et al.  Reversion of toxicity of diphtheria toxoid. , 1971, Japanese journal of medical science & biology.

[27]  A. Ito,et al.  Reversion of toxicity of tetanus toxoid. , 1971, Japanese journal of medical science & biology.

[28]  C. Pope,et al.  The Toxoiding of Purified Diphtheria Toxin. , 1963 .